Showing 1241-1250 of 2101 results for "".
- Kenvue’s Ricciardone Explains New Data on the Value of Teamwork in Moisturizers and Retinoidshttps://modernaesthetics.com/news/kenvues-ricciardone-explains-new-data-on-the-value-of-teamwork-in-moisturizers-and-retinoids/2475347/Data presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, supported the “full sandwich” moisturizer method for new retinoid users who may experience sensitivity from retinization during the skin acclimation period while also suggesting that Neutrogena® H
- Merz Aesthetics Extends Partnership with North Carolina Women’s Teamhttps://modernaesthetics.com/news/merz-aesthetics-extends-partnership-with-north-carolina-womens-team/2473765/Merz Aesthetics announced its continued partnership with the Women’s National Soccer League's North Carolina Courage on Tuesday. “We are proud to continue our partnership with the NC Courage, an organization aligned in our shared values of the importance of confidence and empowerment of w
- 2025 AAD: What’s New and True for Energy-Based Deviceshttps://modernaesthetics.com/news/2025-aad-whats-new-and-true-for-energy-based-devices/2473763/At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Modern Aesthetics sat in on “What’s New and What’s True for Energy-Based Devices (EBDs).” The speakers of this lecture included Suzanne L Kilmer, MD, FAAD; Arielle N.B. Kauvar, MD, FAAD; Merete Haedersdal, MD, PhD, FAAD; Jill S. Wa
- Research Letter: Molecule Enhances Skin Barrier, Reduces Retinoid Side Effectshttps://modernaesthetics.com/news/research-letter-molecule-enhances-skin-barrier-reduces-retinoid-side-effects/2473752/A formulation containing Epicutis Skincare’s proprietary TSC molecule significantly reduced erythema and dryness caused by tretinoin, according to a research letter published in the Journal of Cosmetic Dermatology. The
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com
- Utah Surgeon's LumipenPro Enlists Archetype to Pursue EU MDR Approvalhttps://modernaesthetics.com/news/utah-surgeons-lumipenpro-enlists-archetype-to-pursue-eu-mdr-approval/2473738/Medtech innovation management consultancy Archetype has been appointed to drive the European Medical Device Regulation (EU MDR) approval process for LumipenPro™, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility is res
- Legal Expert Discusses Industry Outlook for 2025https://modernaesthetics.com/news/legal-expert-discusses-industry-outlook-for-2025/2473729/As a partner in the law firm Michelman & Robinson's Commercial & Business Litigation Practice, Madison Dini has a well-informed perspective on the medical industry. Among other trends, Dini expects an uptick in mergers and acquisitions (M&A) activity within medtech and aesthetics in 2
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://modernaesthetics.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related
- Report: Regenerative Aesthetics Exosome Market Poised for Growth Through 2031https://modernaesthetics.com/news/report-regenerative-aesthetics-exosome-market-poised-for-growth-through-2031/2473722/The global regenerative aesthetics exosome products market is projected to experience a compound annual growth rate (CAGR) of 35.5% from 2024 to 2031, according to a report from InsightAce Analytic. Exosome-based therapies with applications in skin reju
- Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc.https://modernaesthetics.com/news/elevai-labs-inc-announces-anticipated-name-change-to-pmgc-holdings-inc/2473721/Elevai Labs Inc. is changing its name to PMGC Holdings Inc., the company announced Friday. A press release also stated that PMGC Holdings Inc. plans to effectuate a strategic reorganization effective on Dec. 20. Along with the name change, the reorganization includes moving from D